Analytic validity of DecisionDx-Melanoma, a gene expression profile test for determining metastatic risk in melanoma patients

• Main Authors: Robert W. Cook (Author), Brooke Middlebrook (Author), Jeff Wilkinson (Author), Kyle R. Covington (Author), Kristen Oelschlager (Author), Federico A. Monzon (Author), John F. Stone (Author)
• Format: Book
• Published: BMC, 2018-02-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract Background The DecisionDx-Melanoma test provides prognostic information for patients with cutaneous melanoma (CM). Using formalin-fixed paraffin-embedded primary tumor tissue, the RT-PCR-based test classifies patients into a low- (Class 1) or high-risk (Class 2) category for recurrence base...